您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > CITCO
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
CITCO
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
CITCO图片
CAS NO:338404-52-7
包装与价格:
包装价格(元)
5mg电议
10mg电议
25mg电议

产品介绍

化学性质

Physical AppearanceA crystalline solid
StorageDesiccate at -20°C
M.Wt436.74
Cas No.338404-52-7
FormulaC19H12Cl3N3OS
SolubilitySoluble in DMSO
Chemical Name(E)-6-(4-chlorophenyl)imidazo[2,1-b]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl) oxime
Canonical SMILESClC1=CC=C(C=C1)C2=C(/C=N/OCC(C=C3Cl)=CC=C3Cl)N4C(SC=C4)=N2
运输条件蓝冰运输或根据您的需求运输。
一般建议为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同厂家不同批次产品溶解度各有差异,仅做参考。若实验所需浓度过大至产品溶解极限,请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存,请尽快用完。

资料参考

CITCO, an imidazothiazole derivative, is a selective agonist of human CAR, with an EC50 value of 49 nM and > 50-fold selectivity to CAR over pregnane X receptor (PXR), and no activity on other nuclear receptors. Upon activation with specific agonists, CAR translocates into the nucleus and binds to the response elements as monomers or CAR/RXR heterodimers. The CAR functions as a xenobiotic receptor, involved in detoxification and clearance of toxic substances from the liver. In addition, activation with selective CAR agonists such as CITCO has also been shown to inhibit growth and expansion of brain tumor stem cells.

Reference:

1. Chakraborty S, Kanakasabai S, Bright JJ. Constitutive androstane receptor agonist CITCO inhibits growth and expansion of brain tumour stem cells. British Journal of Cancer, 2011, 104(3): 448-459.

试验操作

Cell experiment:[1]

Cell lines

T98G, U87MG, DB29 and DB33 glioma cells

Reaction Conditions

2.5 ~ 10 μM CITCO for 48 h incubation

Applications

The brain tumor stem cells (BTSCs) from T98G and U87MG cultured in the absence of CITCO showed 6.8 and 11% Annexin V-positive cells that increased to 62 and 68% following addition of 10 μM CITCO, respectively. Moreover, BTSCs from DB29 and DB33 gliomas showed 3 and 0.5% Annexin V-positive cells that increased to 24 and 41% following treatment with 10 μM CITCO, respectively. CITCO dose-dependently induced apoptosis in BTSCs in culture, but not in normal astrocytes.

Animal experiment:[1]

Animal models

Nude mice subcutaneously injected with U87MG–BTSCs

Dosage form

25 or 100 μg

Intraperitoneal injection; on days 22, 24, 26, 30 and 36

Applications

CITCO at the dose of 25 μg resulted in a significant decrease in tumour growth, which further decreased to an undetectable level after treatment with 100 μg CITCO.

Note

The technical data provided above is for reference only.

References:

1. Chakraborty S, Kanakasabai S, Bright JJ. Constitutive androstane receptor agonist CITCO inhibits growth and expansion of brain tumour stem cells. British Journal of Cancer, 2011, 104(3): 448-459.